Amy Sayre
Family Medicine · Chapmanville, WVNPI 1528025350
Payments from drug & device makers
Across 670 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Pfizer$1K
- AstraZeneca$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$604
- AbbVie$559
- Lilly USA, LLC$540
- plus $5K from 42 others
What the payments were for
- Food & beverage$10,549100%
- Education$470%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,595 in reported general payments places this provider in the 95th percentile of 843 family medicine providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 152 | $203,596 |
| JardianceEmpagliflozin | 63 | $91,121 |
| EliquisApixaban | 88 | $70,015 |
| MounjaroTirzepatide | 60 | $63,009 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $62,278 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $49,833 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 63 | $46,901 |
| XareltoRivaroxaban | 39 | $45,408 |
| LinzessLinaclotide | 47 | $40,548 |
| EntrestoSacubitril/Valsartan | 33 | $29,730 |
| FarxigaDapagliflozin Propanediol | 28 | $29,110 |
| TrulicityDulaglutide | 28 | $28,383 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 36 | $27,985 |
| RybelsusSemaglutide | 15 | $18,826 |
| TradjentaLinagliptin | 16 | $16,511 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,596 | $222,422167 claims |
| Boehringer IngelheimJardiance, Tradjenta | $454 | $107,63179 claims |
| Lilly USA, LLCMounjaro, Trulicity | $540 | $91,39288 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $429 | $71,104109 claims |
| PfizerEliquis | $1,489 | $70,01588 claims |
| Johnson & JohnsonXarelto | $500 | $45,40839 claims |
| AbbVieLinzess, Synthroid | $559 | $44,449102 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,027 | $40,93743 claims |
| NovartisEntresto | $484 | $29,73033 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Chapmanville
- Wilbur SineMorgantown$179K
- Dorian WilliamsMorgantown$169K
- Julie DetempleSouth Charleston$129K
- Clemente DiazRichwood$127K
- John CornellHuntington$94K
- Mark CucuzzellaHarpers Ferry$59K
- Courtney PilkertonMorgantown$45K
- Isha WoofterClarksburg$27K
- Dominick WoofterClarksburg$27K
- Ryan RunyonPrinceton$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.